Table 2.
ADAPTING — responding flexibly and creatively to manage challenges brought by the pandemic. How programme leaders adapted and adopted their management of testing/diagnosis/colonoscopy capacity, access and backlogs during COVID-19. | |
…we came up with different priority levels; A being the top, very urgent and B and C but we also increased, added this Category D, for ‘DO NOT Perform’, at any time, in or out of the pandemic, there’s this list of screening, average risk colonoscopy and surveillance for low-risk adenomas that should just never be done, just remove them from your list, you know. | PR4 P3 |
So certainly there was a backlog, and we undertook, we looked at creating a bit of a lift for the health authorities, of their patients, and we created a bit of an algorithm to risk stratify the patients, incorporating how long they’ve been waiting since their abnormal FIT, and gender, patient age and the FIT value. | PR5 P6 |
So, ther—there were discussions among the leads in the screening centres about how you would identify those ones who are particular risk. So one suggestion was that you would base it on the FIT concentration, the higher the FIT concentration the higher the risk and there is truth in that. | PR3 P7 |
FIT, faecal immunochemical testing.